JP2009530393A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530393A5
JP2009530393A5 JP2009501562A JP2009501562A JP2009530393A5 JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5 JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5
Authority
JP
Japan
Prior art keywords
monocyclic
compound
alkyl
bicyclic
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009501562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/007146 external-priority patent/WO2007111954A2/en
Publication of JP2009530393A publication Critical patent/JP2009530393A/ja
Publication of JP2009530393A5 publication Critical patent/JP2009530393A5/ja
Withdrawn legal-status Critical Current

Links

JP2009501562A 2006-03-23 2007-03-22 プリン化合物およびその使用方法 Withdrawn JP2009530393A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78509306P 2006-03-23 2006-03-23
US78501406P 2006-03-23 2006-03-23
US78509206P 2006-03-23 2006-03-23
US78509406P 2006-03-23 2006-03-23
PCT/US2007/007146 WO2007111954A2 (en) 2006-03-23 2007-03-22 Purine compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009530393A JP2009530393A (ja) 2009-08-27
JP2009530393A5 true JP2009530393A5 (cg-RX-API-DMAC7.html) 2010-05-06

Family

ID=38541654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009501562A Withdrawn JP2009530393A (ja) 2006-03-23 2007-03-22 プリン化合物およびその使用方法

Country Status (10)

Country Link
US (1) US20070238694A1 (cg-RX-API-DMAC7.html)
EP (1) EP1996020A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009530393A (cg-RX-API-DMAC7.html)
KR (1) KR20080110816A (cg-RX-API-DMAC7.html)
AU (1) AU2007229463A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0709124A2 (cg-RX-API-DMAC7.html)
CA (1) CA2643503A1 (cg-RX-API-DMAC7.html)
IL (1) IL193693A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008012185A (cg-RX-API-DMAC7.html)
WO (1) WO2007111954A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484928B2 (ja) * 2004-05-26 2010-06-16 イノテック ファーマシューティカルズ コーポレイション アデノシンa1レセプター・アゴニストとしてのプリン誘導体およびその使用方法
BRPI0515506A (pt) * 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso dos mesmos
WO2007064795A2 (en) * 2005-11-30 2007-06-07 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2010313544A1 (en) * 2009-10-26 2012-05-10 Inotek Pharmaceuticals Corporation Ophthalmic formulation and method of manufacture thereof
PH12012501320A1 (en) 2010-01-11 2013-01-21 Inotek Pharmaceuticals Corp Combination, kit and method of reducing intraocular pressure
SG184221A1 (en) * 2010-03-26 2012-10-30 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
RS56150B1 (sr) 2012-01-26 2017-11-30 Inotek Pharmaceuticals Corp Anhidrovani polimorfi (2r,3s,4r,5r)-5-(6-(ciklopentilamino)-9h-purin-9-yl)-3,4-dihidroksitetrahidrofuran-2-yl)} metil-nitrata i postupak njegove pripreme
MX2015013240A (es) * 2013-03-15 2016-04-07 Inotek Pharmaceuticals Corp Método para proporcionar neuroprotección ocular.
WO2014152723A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
JP2005530759A (ja) * 2002-05-06 2005-10-13 ジェネラブズ テクノロジーズ インコーポレーティッド C型肝炎ウイルス感染症を治療するためのヌクレオシド誘導体
JP4484928B2 (ja) * 2004-05-26 2010-06-16 イノテック ファーマシューティカルズ コーポレイション アデノシンa1レセプター・アゴニストとしてのプリン誘導体およびその使用方法
BRPI0515506A (pt) * 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso dos mesmos

Similar Documents

Publication Publication Date Title
JP2009530393A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
JP2005518350A5 (cg-RX-API-DMAC7.html)
JP2013509411A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2003506354A5 (cg-RX-API-DMAC7.html)
CN111836814A (zh) 稠环化合物、其制备方法及用途
JP2004531517A5 (cg-RX-API-DMAC7.html)
WO2012138894A4 (en) Hsp90 inhibitors
JPWO2019195124A5 (cg-RX-API-DMAC7.html)
JP2009513658A5 (cg-RX-API-DMAC7.html)
JP2008545793A5 (cg-RX-API-DMAC7.html)
JP2005501110A5 (cg-RX-API-DMAC7.html)
JP2019515908A5 (cg-RX-API-DMAC7.html)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2007501779A5 (cg-RX-API-DMAC7.html)
CA2303815A1 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
JP2010522710A5 (cg-RX-API-DMAC7.html)
RU2009144538A (ru) Новые циклические пептидные соединения
JP2007515476A5 (cg-RX-API-DMAC7.html)
RU2014109441A (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
JP2008510758A5 (cg-RX-API-DMAC7.html)
JP2020524178A5 (cg-RX-API-DMAC7.html)
JP2005513017A5 (cg-RX-API-DMAC7.html)
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием